Synthetic polyunsaturated fatty acid conjugated phospholipid yeast engineering bacteria, construction method and application thereof
By constructing a phospholipid synthesis pathway in yeast cells and using the CRISPR/Cas9 system to knock out and integrate related genes, the problems of low production efficiency and high cost of polyunsaturated fatty acid-bound phospholipids in existing technologies have been solved, enabling efficient and economical large-scale production.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- YELLOW SEA FISHERIES RES INST CHINESE ACAD OF FISHERIES SCI
- Filing Date
- 2026-02-12
- Publication Date
- 2026-06-26
AI Technical Summary
Existing technologies make it difficult to achieve large-scale production of polyunsaturated fatty acid-bound phospholipids (PUFAs-PL) efficiently and economically. Chemical synthesis methods carry the risk of double bond destruction, while enzyme-catalyzed synthesis methods are costly and have low reaction efficiency.
Phospholipid synthesis pathways were constructed in yeast cells using genetic engineering techniques. Related genes were knocked out and genes related to phospholipid synthesis, pyruvate synthesis, and polyunsaturated fatty acid synthesis were integrated to form an expression module. Gene knockout and homologous recombination were performed using the CRISPR/Cas9 system to construct the yeast engineered strain PL15.
The efficient synthesis of PUFAs-PL was achieved, increasing phospholipid yield by 7 times to 151.19 mg/g, with an EPA content of 13.2%, thus solving the problems of production efficiency and cost in existing technologies.
Smart Images

Figure CN121699770B_ABST